PACS vs. NHC, ENSG, RDNT, IOVA, ITGR, BHVN, AXSM, INSM, SMMT, and PBH
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include National HealthCare (NHC), The Ensign Group (ENSG), RadNet (RDNT), Iovance Biotherapeutics (IOVA), Integer (ITGR), Biohaven (BHVN), Axsome Therapeutics (AXSM), Insmed (INSM), Summit Therapeutics (SMMT), and Prestige Consumer Healthcare (PBH). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and National HealthCare (NYSE:NHC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.
National HealthCare has a net margin of 6.95% compared to PACS Group's net margin of 0.00%. National HealthCare's return on equity of 6.28% beat PACS Group's return on equity.
In the previous week, PACS Group had 26 more articles in the media than National HealthCare. MarketBeat recorded 34 mentions for PACS Group and 8 mentions for National HealthCare. National HealthCare's average media sentiment score of 0.49 beat PACS Group's score of 0.23 indicating that National HealthCare is being referred to more favorably in the news media.
PACS Group received 10 more outperform votes than National HealthCare when rated by MarketBeat users.
PACS Group presently has a consensus price target of $31.00, suggesting a potential upside of 9.27%. Given PACS Group's higher possible upside, equities research analysts plainly believe PACS Group is more favorable than National HealthCare.
National HealthCare has lower revenue, but higher earnings than PACS Group.
56.4% of National HealthCare shares are held by institutional investors. 13.8% of National HealthCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Summary
PACS Group and National HealthCare tied by winning 6 of the 12 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PACS Group Competitors List
Related Companies and Tools
